MaxCyte, Inc. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
MaxCyte, Inc. (MXCT) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$9.37 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-25
- MaxCyte, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$9.37M.
- MaxCyte, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$8.58M.
- MaxCyte, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$7.96M.
- MaxCyte, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was -$4.95M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$9.37M 10-K · filed 2026-03-25 | |
| 2024-12-31 | -$8.58M 10-K · filed 2026-03-25 | |
| 2023-12-31 | -$7.96M 10-K · filed 2025-03-11 | |
| 2022-12-31 | -$4.95M 10-K · filed 2024-03-12 | -$4.95M 10-K · filed 2023-03-15 |
| 2021-12-31 | -$4.01M 10-K · filed 2023-03-15 | |
| 2020-12-31 | -$2.48M 10-K · filed 2022-03-22 | |
| 2019-12-31 | -$2.71M 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |